Drug class
Anionic surfactant sclerosant; detergent-type venous sclerotherapy agent
Mechanism of action
Disrupts endothelial-cell membranes in the treated vein, causing endothelial injury, thrombosis and subsequent fibrotic occlusion of the vessel. Sodium is a counter-ion and does not create a different sclerosant target.
General use cases
- Sclerotherapy of suitable varicose veins and venous malformations in appropriately selected patients; strength, foam/solution technique and target vessel are product- and jurisdiction-specific
The tetradecyl sulfate anion is the sclerosant active moiety; sodium is the counter-ion. Use and concentration are formulation-specific.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
